CTI Clinical Trial and Consulting Services Announces the Formation of Italian Subsidiary and Opens Office in Milan, Italy
CTI Clinical Trial and Consulting Services (CTI) announces that it has opened an office in Milan, Italy. The office is opened through its newly created wholly-owned subsidiary, CTI Clinical Trial and Consulting Services Italy, S.R.L.
CTI Clinical Trial and Consulting Services
(CTI) announces that it has opened an office in Milan, Italy. The office is opened through its newly created wholly-owned subsidiary, CTI Clinical Trial and Consulting Services Italy, S.R.L.
“We believe that the market for clinical research is continuing its growth throughout Europe, and Italy is a key location,” states Patrick Earley, General Manager at CTI. “Milan has a very dynamic economy, serving as a hub for the Italian pharmaceutical and biotechnology industries, which makes it ideal for a new location. We have had ongoing relationships with many key Italian research leaders for several years, and this expansion will allow us to continue to enhance our collaborations.”
CTI has been working for nearly fifteen years in the drug development industry in North America, Europe, and South America, specializing in clinical research programs involving critically ill patient populations. The office in Italy is the seventh CTI office in Europe and the second European office to open in 2013.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
